Covered recipient · General Payments record
ABU N AHMED
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$3,655.11
- Reported across 180 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $190.56 | 8 |
| Education | $84.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $84.99 | 1 |
| PFIZER INC. | $45.18 | 2 |
| SpringWorks Therapeutics, Inc. | $28.53 | 1 |
| GlaxoSmithKline, LLC. | $26.58 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.20 | 1 |
| Rigel Pharmaceuticals, Inc. | $24.49 | 1 |
| Mirati Therapeutics, Inc. | $23.32 | 1 |
| Sumitomo Pharma America, Inc. | $16.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $84.99 | 04/12/2024 | Education | Undisputed | 01/23/2026 | 1139346330 | CMS |
| GlaxoSmithKline, LLC. | $26.58 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116312883 | CMS |
| Mirati Therapeutics, Inc. | $23.32 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117165858 | CMS |
| Novartis Pharmaceuticals Corporation | $26.20 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086767767 | CMS |
| PFIZER INC. | $26.44 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131284523 | CMS |
| PFIZER INC. | $18.74 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130873475 | CMS |
| Rigel Pharmaceuticals, Inc. | $24.49 | 07/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145204554 | CMS |
| SpringWorks Therapeutics, Inc. | $28.53 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085802438 | CMS |
| Sumitomo Pharma America, Inc. | $16.26 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148819172 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.